Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2016

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 114th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

R BurgessSponsor

20 cosponsors · 13 D, 7 R

7 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2016

What it does: CRS summary · Introduced in House · Sep 22, 2016

Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2016

This bill amends titles II (Old Age, Survivors, and Disability Insurance) and XVIII (Medicare) of the Social Security Act to indefinitely extend Medicare coverage of immunosuppressive drugs for kidney transplant recipients. Under current law, such coverage is limited to 36 months following a transplant.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2016

Latest action (Sep 29, 2016): Referred to the Subcommittee on Health.

Policy area: Health · Origin: House · Introduced: Sep 22, 2016

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.